1KBH

Mutual Synergistic Folding in the Interaction Between Nuclear Receptor Coactivators CBP and ACTR

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_13C-separated_NOESY	3mM U-15N,13C-CBP:2059-2117 6mM 14N,12C-ACTR:1018-1088	10 mM Tris, 50 mM NaCl 100%D2O	60 mM	6.6	ambient	31
2	4D_13C-separated_NOESY	3mM U-15N,13C-CBP:2059-2117 6mM 14N,12C-ACTR:1018-1088	10 mM Tris, 50 mM NaCl 95%H2O,5%D2O	60 mM	6.6	ambient	31
3	3D_15N-separated_NOESY	3mM U-15N,12C-CBP:2059-2117 6mM 14N,12C-ACTR:1018-1088	10 mM Tris, 50 mM NaCl 95%H2O,5%D2O	60 mM	6.6	ambient	31
4	12C-filtered/13C-edited-NOESY	3mM U-15N,13C-CBP:2059-2117 6mM 14N,12C-ACTR:1018-1088	10 mM Tris, 50 mM NaCl 100%D2O	60 mM	6.6	ambient	31
5	HNHA	3mM U-15N,12C-CBP:2059-2117 6mM 14N,12C-ACTR:1018-1088	10 mM Tris, 50 mM NaCl 95%H2O,5%D2O	60 mM	6.6	ambient	31
6	HNHB	3mM U-15N,12C-CBP:2059-2117 6mM 14N,12C-ACTR:1018-1088	10 mM Tris, 50 mM NaCl 95%H2O,5%D2O	60 mM	6.6	ambient	31

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	600
2	Bruker	AMX	500
3	Bruker	DMX	750
4	Bruker	DRX	800
5	Bruker	AMX	600

NMR Refinement
Method	Details	Software
Dyana, Sane, Amber	200 structures originally calculated using unambiguous restraints in Dyana followed by the addition of ambiguous restraints for simulated annealing of the top 100 Dyana structures in Amber. Best 20 structures selected to represent the structure of the ACTR/CBP complex.	DYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations,structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations,lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	DYANA	1.5	Wuthrich, et al.
2	processing	NMRPipe	1	Delagio, et al.
3	collection	XwinNMR	1	Bruker
4	collection	UXNMR	1	Bruker
5	refinement	Amber	5.0	Case, et al.
6	data analysis	NMRView	3.0	Johnson, B., et al.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.